Figure 4.
HXMM improved BRVO rat retinal function. (a) The typical ERG (dark-adaptation response 3.0) performance. (b) BRVO rat amplification of the b (d3.0) wave after modeling 0, 1, 3, 5, 7, 10, 14, and 21 d postocclusion. (c) BRVO rats peak time of the b (d3.0) wave after modeling 0, 1, 3, 5, 7, 10, 14, and 21 d postocclusion. (d) BRVO rat amplitude of the OPsO2 wave after modeling 0, 1, 3, 5, 7, 10, 14, and 21 d postocclusion. (e) BRVO rat amplitude of the ∑OPs1–4 wave after modeling 0, 1, 3, 5, 7, 10, 14, and 21 d postocclusion. The statistical significance was determined by one-way ANOVA. Data are presented as the mean ± SEM. All analyses were performed in duplicate. n = 12 rats per group. ∗p < 0.05, HIGH group vs. CK group; #p < 0.05, MOD group vs. CK group.